Company Logo
US NY Suffolk County Shirley Agricultural Biotechnology

ulocuplumab

Agricultural Biotechnology

Updated on Apr 2, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for ulocuplumab with ID of: 4141146
Ramos and K562 cell lines were treated with different concentrations of Ulocuplumab (BMS-936564) and AMD3100 for 48 hrs followed by running the samples on flow cytometer to study the % SIA. Treatment with AMD3100 in Ramos/ K562/CLL did not induce significant % SIA as compared to Ulocuplumab (BMS-936564). In contrast, Ulocuplumab (BMS-936564) induced significant % SIA in Ramos and CLL cells (CXCR4+), but not in K562 (CXCR4-) as evaluated by flow cytometry).
View all posts by Bella SmithIs this your business? Claim this post.Contact Bella Smith
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.